New Pathology Testing Device Enables Oncologists to Diagnose Cancer in One Hour at the Bedside with 96% Accuracy

Smartphone-based lab testing device could eliminate need to send biopsies to pathology laboratories

For years, pathologists have wondered when technology would make it feasible to diagnose cancer at the patient’s beside. Eliminating the need for a traditional biopsy that goes off to the anatomic pathology laboratory, and requires 24 hours or more to process the tissue and evaluate the case. Now scientists at Harvard Medical School may be close to perfecting a device that can allow oncologists to do exactly that type of bedside analysis and produce a diagnosis in 60 minutes or less!

The heart of this technology is a new microchip that interacts with smartphone software. Researchers believe it will be possible for physicians to diagnose cancer at the bedside in less than 60 minutes.


Hematology on a Chip: University of Southampton Develops POC Blood Analysis

In conjunction with Phillips Research, a team from the University of Southampton is looking to revolutionize blood analysis

Point-of-care blood cell analysis in doctor’s offices could soon be much faster and more convenient. In conjunction with Philips Research, a team of researchers at England’s University of Southampton is developing a miniaturized cell analysis device with the  goal of eventually delivering a low cost, high speed, and inexpensive system to perform CBCs (complete blood counts) in point-of-care settings.

The team recently developed a microfluidic single-cell impedance cytometer with the ability to execute a white cell differential count. A microchip within the cytometer uses microfluidics to assess various cells in the blood. The electrical properties of the blood cells are assessed while the blood actually flows through the chip. The measurements are used to determine and count the different types of cells and would allow physicians to diagnose several different types of diseases. The device can identify three types of white blood cells (T-lymphocytes, monocytes and neutrophils) quicker and more inexpensively than current systems.